Allergies affect tens of millions of adults and children in the United States. According to the CDC, over 19 million adults and over 5 million children in the US suffer from seasonal allergies (hay fever), and over 4.5 million children have food allergies.1
Allergy testing can help your patient know what exposures to avoid, and just as important, what exposures are safe. The ImmunoCAP IgE blood test from Quest Diagnostics makes it possible to easily identify allergen-specific triggers, for improved patient management and outcomes.
Understanding the allergy-asthma connection
Research shows that allergy is a risk factor for asthma,2 as exposure to allergens can increase asthma symptoms and trigger attacks. The CDC recommends allergy testing for patients with asthma to help close gaps in care and mitigate risk for other respiratory illnesses.3
Identifying your patients’ allergy triggers with ImmunoCAP supports better asthma management and control for improved health outcomes and fewer office visits and hospitalizations for your patients.”
References
- CDC National Center for Health Statistics. Allergy and hay fever. Updated March 1, 2021. Accessed September 6, 2021. https://www.cdc.gov/nchs/fastats/allergies.htm
- Nelson HS, Allergen and irritant control: importance and implementation. Clin Cornerstone. 1998:1(2):57-68. doi:10.1016/s1098-3597(98)80006-9
- CDC. Allergy testing for persons with asthma: frequently asked questions. Accessed September 4, 2020. https://www.cdc.gov/asthma/pdfs/AA_Fact_Sheet.pdf doi: 10.4168/aair.2018.10.2.97
- Chan SK, Leung DYM. Dog and cat allergies: current state of diagnostic approaches and challenges. Allergy Asthma Immunol Res. 2018;10(2):97-105. doi:10.4168/aair.2018.10.2.97
https://www.questdiagnostics.com/healthcare-professionals/about-our-tests/allergy-asthma#accordion-3841516770-item-764e984df9